Invacare Corporation (IVC) EPS Estimated At $-0.42

January 22, 2018 - By Jan Rainey

 Invacare Corporation (IVC) EPS Estimated At $ 0.42
Investors sentiment decreased to 1.63 in Q3 2017. Its down 0.31, from 1.94 in 2017Q2. It dived, as 11 investors sold Invacare Corporation shares while 29 reduced holdings. 12 funds opened positions while 53 raised stakes. 42.33 million shares or 11.81% more from 37.86 million shares in 2017Q2 were reported.
Rhumbline Advisers holds 0% or 67,264 shares in its portfolio. Granahan Ma holds 0.66% or 505,111 shares. Moreover, American Interest Grp Inc has 0% invested in Invacare Corporation (NYSE:IVC) for 25,305 shares. Gru One Trading Lp has 0% invested in Invacare Corporation (NYSE:IVC) for 7,240 shares. Perceptive Ltd Liability Corporation reported 200,000 shares or 0.15% of all its holdings. 204,327 were accumulated by Prospector Prtn Limited Liability Corp. Zurcher Kantonalbank (Zurich Cantonalbank), a Switzerland-based fund reported 422 shares. Parametric Associates Limited Com holds 0% of its portfolio in Invacare Corporation (NYSE:IVC) for 145,622 shares. Price T Rowe Associate Md holds 19,300 shares or 0% of its portfolio. Parkside Bank & Trust And Tru accumulated 22 shares or 0% of the stock. Pub Employees Retirement Sys Of Ohio holds 0% or 8,151 shares in its portfolio. 20,619 were accumulated by Bnp Paribas Arbitrage. Quantbot Tech Lp has invested 0.01% of its portfolio in Invacare Corporation (NYSE:IVC). Employees Retirement Association Of Colorado reported 7,352 shares. Thrivent For Lutherans owns 19,930 shares.

Since September 13, 2017, it had 0 insider purchases, and 1 insider sale for $94,697 activity.

Analysts expect Invacare Corporation (NYSE:IVC) to report $-0.42 EPS on February, 8.They anticipate $0.04 EPS change or 8.70 % from last quarter’s $-0.46 EPS. After having $-0.41 EPS previously, Invacare Corporation’s analysts see 2.44 % EPS growth. The stock increased 1.82% or $0.31 during the last trading session, reaching $17.22. About 139,808 shares traded. Invacare Corporation (NYSE:IVC) has risen 42.93% since January 22, 2017 and is uptrending. It has outperformed by 26.23% the S&P500.

Invacare Corporation (NYSE:IVC) Ratings Coverage

Among 2 analysts covering Invacare Corporation (NYSE:IVC), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Invacare Corporation had 3 analyst reports since April 5, 2017 according to SRatingsIntel. KeyBanc Capital Markets maintained the stock with “Buy” rating in Tuesday, September 26 report. The stock of Invacare Corporation (NYSE:IVC) has “Overweight” rating given on Monday, May 1 by Stephens. The firm has “Equal Weight” rating by Stephens given on Wednesday, April 5.

Invacare Corporation, together with its subsidiaries, designs, makes, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company has market cap of $565.39 million. The firm operates through four divisions: North America/Home Medical Equipment, Institutional Products Group, Europe, and the Asia/Pacific. It currently has negative earnings. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products.

Another recent and important Invacare Corporation (NYSE:IVC) news was published by which published an article titled: “Invacare Corporation to Host Conference Call and Webcast to Discuss Fourth …” on January 19, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: